116890 Adenosine Kinase Inhibitor - CAS 214697-26-4 - Calbiochem

116890
가격을 검색할 수 없습니다
Minimum Quantity needs to be mulitiple of
가격 문의 추가 정보
()이 할인됨
 
가격 문의
재고 없음재고 없음
예상 출고 가능일 
단종품
제한된 수량 가능
재고여부 확인
    Remaining: will advise
      Remaining: will advise
      추천사항
      고객 서비스로 문의
      Contact Customer Service
      가격 및 재고 조회

      개요

      Replacement Information

      주요 사양표

      Empirical FormulaCAS #
      C₂₂H₁₉BrN₆O 214697-26-4

      가격 및 재고여부

      카탈로그 번호 재고 정보패킹 포장 단위 가격(VAT 별도) 수량
      116890-5MGCN
      재고 정보 검색...
      재고 없음재고 없음
      예상 출고 가능일 
      단종품
      제한된 수량 가능
      재고여부 확인
        Remaining: will advise
          Remaining: will advise
          추천사항
          고객 서비스로 문의
          Contact Customer Service

          Plastic ampoule 5 mg
          가격 검색...
          가격을 검색할 수 없습니다
          Minimum Quantity needs to be mulitiple of
          가격 문의 추가 정보
          ()이 할인됨
           
          가격 문의
          Description
          OverviewA cell-permeable, non-nucleoside pyridopyrimidine compound that acts as a potent, adenosine-competitive, and reversible adenosine kinase (AK) inhibitor (IC50 = 50.7 nM using intact IMR-32 cells and 1.7 nM in cell-free assays using rat brain cytosolic AK). The inhibitory effect is not species-specific and its pharmacological selectivity is confirmed using a panel of more than 80 other enzymes, ion channels, and receptors, including various adesine receptors. It readily crosses the blood-brain barrier and is shown to be efficacious in in vivo animal models via various administration methods (i.p., p.o., s.c.).

          Please note that the molecular weight for this compound is batch-specific due to variable water content. Please refer to the vial label or the certificate of analysis for the batch-specific molecular weight. The molecular weight provided represents the baseline molecular weight without salt molecules.
          Catalogue Number116890
          Brand Family Calbiochem®
          Synonyms4-Amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin-3-yl)pyrido[2,3-d]pyrimidine, 2HCl, ABT-702
          References
          ReferencesDe Vry, J., et al. 2004. Eur. J. Pharmacol. 491, 137.
          Suzuki, R., et al. 2001. Br. J. Pharmacol. 132, 1615.
          Boyle, D.L., et al. 2001. J. Pharmacol. Exp. Ther. 296, 495.
          Kowaluk, E.A., et al. 2000. J. Pharmacol. Exp. Ther. 295, 1165.
          Jarvis, M.F., et al. 2000. J. Pharmacol. Exp. Ther. 295, 1156.
          Product Information
          CAS number214697-26-4
          ATP CompetitiveN
          FormYellow to orange solid
          Hill FormulaC₂₂H₁₉BrN₆O
          Chemical formulaC₂₂H₁₉BrN₆O
          Hygroscopic Hygroscopic
          ReversibleY
          Structure formula ImageStructure formula Image
          Quality LevelMQ100
          Applications
          Biological Information
          Primary TargetAdenosine Kinase
          Primary Target IC<sub>50</sub>50.7 nM inhibiting adenosine kinase (AK) using intact IMR-32 cells and 1.7 nM in cell-free assays using rat brain cytosolic AK
          Purity≥90% by HPLC
          Physicochemical Information
          Cell permeableY
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          Safety Information
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Ambient Temperature Only
          Toxicity Standard Handling
          Storage +2°C to +8°C
          Protect from Light Protect from light
          Hygroscopic Hygroscopic
          Do not freeze Ok to freeze
          Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
          Packaging Information
          Transport Information
          Supplemental Information
          Specifications

          Documentation

          Adenosine Kinase Inhibitor - CAS 214697-26-4 - Calbiochem MSDS

          타이틀

          물질안전보건자료(MSDS) 

          Adenosine Kinase Inhibitor - CAS 214697-26-4 - Calbiochem Certificates of Analysis

          TitleLot Number
          116890

          References

          참고문헌 보기
          De Vry, J., et al. 2004. Eur. J. Pharmacol. 491, 137.
          Suzuki, R., et al. 2001. Br. J. Pharmacol. 132, 1615.
          Boyle, D.L., et al. 2001. J. Pharmacol. Exp. Ther. 296, 495.
          Kowaluk, E.A., et al. 2000. J. Pharmacol. Exp. Ther. 295, 1165.
          Jarvis, M.F., et al. 2000. J. Pharmacol. Exp. Ther. 295, 1156.
          Data Sheet

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision17-December-2018 JSW
          Synonyms4-Amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin-3-yl)pyrido[2,3-d]pyrimidine, 2HCl, ABT-702
          DescriptionA cell-permeable, non-nucleoside pyridopyrimidine compound that acts as a potent, adenosine-competitive, and reversible adenosine kinase (AK) inhibitor (IC50 = 50.7 nM using intact IMR-32 cells and 1.7 nM in cell-free assays using rat brain cytosolic AK). The inhibitory effect is not species-specific and its pharmacological selectivity is confirmed using a panel of more than 80 other enzymes, ion channels, and receptors, including various adesine receptors. It readily crosses the blood-brain barrier and is shown to be efficacious in in vivo animal models via various administration methods (i.p., p.o., s.c.).
          FormYellow to orange solid
          CAS number214697-26-4
          Chemical formulaC₂₂H₁₉BrN₆O
          Structure formulaStructure formula
          Purity≥90% by HPLC
          SolubilityDMSO (20 mg/ml)
          Storage +2°C to +8°C
          Hygroscopic
          Protect from light
          Do Not Freeze Ok to freeze
          Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
          Toxicity Standard Handling
          ReferencesDe Vry, J., et al. 2004. Eur. J. Pharmacol. 491, 137.
          Suzuki, R., et al. 2001. Br. J. Pharmacol. 132, 1615.
          Boyle, D.L., et al. 2001. J. Pharmacol. Exp. Ther. 296, 495.
          Kowaluk, E.A., et al. 2000. J. Pharmacol. Exp. Ther. 295, 1165.
          Jarvis, M.F., et al. 2000. J. Pharmacol. Exp. Ther. 295, 1156.